Search research articles
Contact Us
Filters
Showing results (21-30 of 53) with videos related to
Page
of 6
Sort By:
Computers in Biology and Medicine
|
May 17, 2025
Improving necrosis estimation in MR-guided prostate focused ultrasound ablations with a probabilistic thermal dose model
Simon Schröer, Julian Glandorf, Daniel Düx, et al.
Springerplus
|
July 16, 2013
Incidence of synchronous and metachronous adrenal metastases following tumor nephrectomy in renal cell cancer patients: a retrospective bi-center analysis
Inga Peters, Milan Hora, Thomas R Herrmann, et al.
BMC Cancer
|
April 24, 2013
Reduced mRNA expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer
Hossein Tezval, Faranaz Atschekzei, Inga Peters, et al.
Oncology Reports
|
October 2, 2018
DNA methylation of neural EGFL like 1 (NELL1) is associated with advanced disease and the metastatic state of renal cell cancer patients
Inga Peters, Natalia Dubrowinskaja, Jörg Hennenlotter, et al.
World Journal of Urology
|
March 17, 2015
Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results
Susanne Tewes, Katja Hueper, Dagmar Hartung, et al.
Advances in Therapy
|
May 22, 2021
Comparison of PD-L1 Scores in Primary Kidney Tumors Versus Accompanying Venous Tumor Thrombi: Retrospective, Comparative, Monocentric Study in Treatment-Naive Patients
Mehrdad Mazdak, Rieke Ringlstetter, Pouriya Faraj Tabrizi, et al.
Targeted Oncology
|
September 19, 2014
Decreased mRNA expression of GATA1 and GATA2 is associated with tumor aggressiveness and poor outcome in clear cell renal cell carcinoma
Inga Peters, Natalia Dubrowinskaja, Hossein Tezval, et al.
Advances in Therapy
|
October 25, 2013
Age distribution for partial and radical nephrectomy: whose nephrons are being spared?
Christoph von Klot, Thomas R Herrmann, Gerd Wegener, et al.
Plos One
|
March 18, 2014
DNA methylation biomarkers predict progression-free and overall survival of metastatic renal cell cancer (mRCC) treated with antiangiogenic therapies
Inga Peters, Natalia Dubrowinskaja, Mahmoud Abbas, et al.
BJU International
|
February 1, 2012
GATA5 CpG island methylation in renal cell cancer: a potential biomarker for metastasis and disease progression
Inga Peters, Hendrik Eggers, Faranaz Atschekzei, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 53) with videos related to
Sort By:
Page
of 6
Computers in Biology and Medicine
|
May 17, 2025
Improving necrosis estimation in MR-guided prostate focused ultrasound ablations with a probabilistic thermal dose model
Simon Schröer, Julian Glandorf, Daniel Düx, et al.
Springerplus
|
July 16, 2013
Incidence of synchronous and metachronous adrenal metastases following tumor nephrectomy in renal cell cancer patients: a retrospective bi-center analysis
Inga Peters, Milan Hora, Thomas R Herrmann, et al.
BMC Cancer
|
April 24, 2013
Reduced mRNA expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer
Hossein Tezval, Faranaz Atschekzei, Inga Peters, et al.
Oncology Reports
|
October 2, 2018
DNA methylation of neural EGFL like 1 (NELL1) is associated with advanced disease and the metastatic state of renal cell cancer patients
Inga Peters, Natalia Dubrowinskaja, Jörg Hennenlotter, et al.
World Journal of Urology
|
March 17, 2015
Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results
Susanne Tewes, Katja Hueper, Dagmar Hartung, et al.
Advances in Therapy
|
May 22, 2021
Comparison of PD-L1 Scores in Primary Kidney Tumors Versus Accompanying Venous Tumor Thrombi: Retrospective, Comparative, Monocentric Study in Treatment-Naive Patients
Mehrdad Mazdak, Rieke Ringlstetter, Pouriya Faraj Tabrizi, et al.
Targeted Oncology
|
September 19, 2014
Decreased mRNA expression of GATA1 and GATA2 is associated with tumor aggressiveness and poor outcome in clear cell renal cell carcinoma
Inga Peters, Natalia Dubrowinskaja, Hossein Tezval, et al.
Advances in Therapy
|
October 25, 2013
Age distribution for partial and radical nephrectomy: whose nephrons are being spared?
Christoph von Klot, Thomas R Herrmann, Gerd Wegener, et al.
Plos One
|
March 18, 2014
DNA methylation biomarkers predict progression-free and overall survival of metastatic renal cell cancer (mRCC) treated with antiangiogenic therapies
Inga Peters, Natalia Dubrowinskaja, Mahmoud Abbas, et al.
BJU International
|
February 1, 2012
GATA5 CpG island methylation in renal cell cancer: a potential biomarker for metastasis and disease progression
Inga Peters, Hendrik Eggers, Faranaz Atschekzei, et al.
Page
of 6